Catabasis Pharmaceuticals begins Phase lll DMD trial of edasalonexent
Catabasis Pharmaceuticals has initiated a Phase lll PolarisDMD trial to evaluate the efficacy and safety of edasalonexent for the treatment…
DMD Catabasis Pharmaceuticals edasalonexent
